A Nonsteroidal Reversal Agent Inhibits Allopregnanolone Modulation of α1β3δ GABAA Receptors
Xiaojuan Zhou, Youssef Jounaïdi, Keith W. Miller
The paper identifies DKD99, a nonsteroidal agent that reverses allopregnanolone's modulation of α1β3δ GABAA receptors without affecting GABA's action.
bioRxiv · Apr 17, 2026 · PreprintPharmacology & Toxicology